FremEst OÜ
FremEst OÜ is Osaühing. The main activity is Lepinguline toitlustusteenus jm toitlustamine (56221). The company is located in Harju maakond. Founded 27/08/2007. Share capital is 2,556 €. 2025 figures: revenue 118,043 €, profit -8,432 €, employees 3. Taxes for II quarter of 2026 were 7,990 €. No tax debt.
Key figures
- Year
- 2024
- Revenue
- 127,150 €
- Net profit
- 12,412 €
- Employees
- 2
Signals
Financials
2024: revenue 127,150 €, net profit 12,412 €.